Blindness and Low Vision
6
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss
V-NAV Usability Study: End Users Trying the Vortant Indoor Navigation Tool
A Pilot Study Comparing Performance of Blind Participants on 12 Tasks, With and Without the ARIA Device
The Effect of Social Skills Training in Visually Impaired Adolescents
Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
Blueberry Effects on Dark Vision and Glare Recovery